Philip is a Sr. Business Analyst based in Lifescience Dynamics’ HQ in London. Philip holds a PhD from Imperial College London, where he developed platform processes to improve the manufacture of biosimilars. He holds an MEng in Chemical Engineering from Imperial College London. As a research associate at Imperial College London he used computational tools to optimise production processes of biologics in co-operation with MedImmune.

He has gathered CI experience spanning a number of indications from rare diseases, to work on global top 10 assets through primary and secondary work. His expertise is in CI monitoring projects with a focus on blockbuster assets, as well as anti-infectives.

Philip is fluent in English, German and Polish.

Founded in 2004, Lifescience Dynamics is a decision support firm helping life science companies (pharmaceutical, biotechnology, diagnostics and medical devices) with strategic insight and foresight to improve their assumptions, enabling them to make better decisions. Typical projects undertaken aim to address clients’ business issues and challenges to maximise the full commercial potential of their assets. Lifescience Dynamics work with the top 20 global pharmaceutical companies and have recently been awarded the prestigious Queens Award for Enterprise in the category of International Trade. Their complementary competencies lie at the intersection of our three practice areas: • Market research (qualitative and quantitative) • Competitive intelligence (primary and secondary research) • Market access, pricing and reimbursement Lifescience Dynamics has a truly global reach, leveraging their headquarters in central London, a cosmopolitan hub with its internationally ranked universities and global talent pool. They have capitalised by attracting and retaining a talented team of internationally diverse, multi-lingual and scientifically-trained individuals. The company also has international offices in San Francisco and New York, with plans to expand further into the US, Asia and Europe in the coming years.